Cargando…
Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
OBJECTIVES: Unfractionated heparin (UFH) is the commonly used anticoagulant to prevent clotting of the ECMO circuit and thrombosis of the cannulated vessels. A side effect of UFH is heparin-induced thrombocytopenia (HIT). Little is known about HIT during ECMO and the impact of changing anticoagulati...
Autores principales: | Lubnow, Matthias, Berger, Johannes, Schneckenpointner, Roland, Zeman, Florian, Lunz, Dirk, Philipp, Alois, Foltan, Maik, Lehle, Karla, Heimerl, Susanne, Hart, Christina, Schmid, Christof, Fisser, Christoph, Müller, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359525/ https://www.ncbi.nlm.nih.gov/pubmed/35939484 http://dx.doi.org/10.1371/journal.pone.0272577 |
Ejemplares similares
-
Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
por: Fisser, Christoph, et al.
Publicado: (2021) -
Arterial and venous vascular complications in patients requiring peripheral venoarterial extracorporeal membrane oxygenation
por: Fisser, Christoph, et al.
Publicado: (2022) -
Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)—Comparison of VA- versus VV ECMO
por: Appelt, Hannah, et al.
Publicado: (2020) -
Technical Complications during Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange – Retrospective Analysis of 265 Cases
por: Lubnow, Matthias, et al.
Publicado: (2014) -
Life span of different extracorporeal membrane systems for severe respiratory failure in the clinical practice
por: Philipp, Alois, et al.
Publicado: (2018)